India, March 17 -- The Government of India has issued a release:
With a view to strengthen the domestic biopharmaceutical sector and enhance global competitiveness in biologics and biosimilars, the Government has announced the Biopharma SHAKTI scheme with an outlay of Rs.10,000 crore over five years with an objective to build a globally competitive domestic ecosystem for biologics and biosimilars to support affordable healthcare in India and enable India to emerge as a global biopharma manufacturing and innovation hub. The contours of the scheme are under deliberation.
The Biopharma SHAKTI aims to focus on following components:
Under the scheme, it is envisaged to enable faster, globally credible approvals by strengthening the CDSCO thro...